GOEDGEKEURDE DATAVERZOEKEN
  1. R. van Boxtel, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  2. R. Bernards, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Carcinogenesis
  3. F. Weeber, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  4. W. Kloosterman, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  5. H. van Snellenberg, Hartwig Medical Foundation, for the purpose of the collaboration with Hartwig Medical Foundation Australia
  6. S. Groenland, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Medical Oncology and Clinical Pharmacology
  7. E. Voest, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  8. J. Aerts, Erasmus Medical Center, section Lung Diseases
  9. E. Voest, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  10. E. Cuppen / R. Koster, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  11. M. Lolkema, Erasmus Medical Center, section Internal Oncology
  12. H. Verheul / C. Jimenez, VU University Medical Center, section Medical Oncology
  13. M. van der Heijden, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Carcinogenesis
  14. J. Martens, Erasmus Medical Center, section Internal Oncology
  15. L. Hoes, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology
  16. R. Fijneman, Netherlands Cancer Institute – Antoni van Leeuwenhoek, department of Pathology
  17. N. Lopez Bigas, Institute for Research in Biomedicine (Barcelona), Genomics
  18. E. Cuppen, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  19. E. Cuppen, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  20. H. van Snellenberg, Hartwig Medical Foundation, for the purpose of testing IBM Watson
  21. P. van Diest, University Medical Center Utrecht, department of Pathology
  22. S. Nik-Zainal, University of Cambridge, Academic Department of Medical Genetics
  23. E. Voest, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  24. N. Lopez Bigas, IRB Barcelona, Biomedical Genomics
  25. K. Zwinderman, Academic Medical Center, Oncogenomics / KEBB
  26. J. Martens, Erasmus Medical Center, section Internal Oncology
  27. E. Wiemer, Erasmus Medical Center, section Medical Oncology
  28. M. Lolkema, Erasmus Medical Center, section Internal Oncology
  29. J. Boormans, Erasmus Medisch Center, department Urology
  30. B. Mostert, Erasmus Medical Center, section Internal Oncology
  31. D. Thomas, Garvan Institute of Medical Research, department Genomic Cancer Medicine
  32. D. Wedge, University of Oxford, Big Data Institute
  33. B. Mostert, Erasmus Medisch Center, section of Medical Oncology